PMV Pharmaceuticals's total assets for Q3 2025 were $133.84M, a decrease of -12.44% from the previous quarter. PMVP total liabilities were $12.85M for the fiscal quarter, a 4.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.